Boston Scientific Vessix RDN deviceBoston Scientific Corporation took the opportunity presented by EuroPCR congress in Paris last week, to report interim data from its renal denervation study, tagged the REDUCE-HTN clinical program. Patients treated with the Vessix™ Renal Denervation System showed a significant and sustained reduction in the blood pressure.
Teleflex Incorporated (TFX), a leading global provider of medical devices for critical care and surgery, has announced it has received FDA 510(k) clearance to market its ARROW® NextStep® Retrograde Femoral Length Dialysis Catheters. Designed for clinician ease of insertion and sustained high flow rates, the ARROW NextStep Retrograde Femoral Length Catheters further strengthen the NextStep Hemodialysis Catheter portfolio.
St. Jude Medical, Inc. (STJ), a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval to begin the EnligHTN IV Renal Denervation Study, the first U.S. trial using the EnligHTN™ Multi-Electrode Renal Denervation System to treat patients with drug-resistant high blood pressure.
Results from the first, large multi-center study evaluating Selective Internal Radiation Therapy (SIRT) with SIR-Spheres® microspheres in patients ages 70 years and older were released today at the American Society of Clinical Oncology (ASCO) Annual Meeting. According to investigators, the use of SIR-Spheres microspheres in elderly patients with unresectable colorectal liver metastases (mCRC) appears to be as effective and well-tolerated as in younger patients.1 The findings were released by lead investigator of the MORE study, Andrew S. Kennedy, M.D., F.A.C.R.O., Director, Radiation Oncology Research at the Sarah Cannon Research Institute, Nashville, Tenn.
A smoking-cessation medication may be a viable option for the treatment of alcohol dependence, according to a study by scientists at the National Institutes of Health. The study found that varenicline (marketed under the name Chantix), approved in 2006 to help people stop smoking, significantly reduced alcohol consumption and craving among people who are alcohol-dependent. The findings were published online in the Journal of Addiction Medicine.
Quienes reducen la cantidad de carne que ingieren y prefieren las frutas y las verduras son menos propensos a morir en cualquier período evaluado, según un nuevo estudio. "Esto se suma a las pruebas de los potenciales beneficios de la alimentación vegetariana para la prevención de las enfermedades crónicas y la promoción de la longevidad", dijo el autor principal del estudio, doctor Michael Orlich, de Loma Linda University, California.
Data that was presented at the American Urological Association (AUA) Annual Meeting (4–8 May, San Deigo, USA) demonstrated that treatment for benign prostatic hyperplasia with GreenLight XPS laser therapy with MoXy fibre (American Medical Systems), instead of transurethral resection of the prostate (TURP), resulted in significantly shorter hospitalisation, catheterisation, and recovery times for patients, while maintaining equivalent safety and efficacy.
Women who had sufficient amounts of vitamin D were 32 percent less likely to develop fibroids than women with insufficient vitamin D, according to a study from researchers at the National Institutes of Health.
The National Institutes of Health is looking for volunteers to take part in a study to compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes. Beginning recruitment in June, the project is called the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study.
St. Jude Medical, Inc. (St. Paul, MN) announced US Food and Drug Administration (FDA) approval to begin the EnligHTN IV renal denervation study, the first United States trial using the EnligHTN multielectrode renal denervation system to treat patients with drug-resistant high blood pressure.
NeoTract announced the successful results of the 206-patient LIFT investigational device exemption study, a multicentre randomised, blinded study in patients with benign prostatic hyperplasia.
Boston Scientific Corporation (BSX) continues to demonstrate its commitment to women s health by providing a research and education grant of more than $1 million to the Pelvic Floor Disorders Network (PFDN) for the SUPeR clinical trial. The SUPeR study will evaluate treatment outcomes of two different surgical options for women with uterine prolapse, a form of pelvic organ prolapse.
Medtronic announced on 4 June 2013 that the Pacific Plus percutaneous transluminal angioplasty (PTA) catheter has received both FDA clearance and the CE mark. The launch of the new peripheral balloon catheter is underway in the United States and internationally.
Las dietas reducidas en carbohidratos, grasas y el régimen alimentario mediterráneo serían igualmente beneficiosos para las personas con sobrepeso y enfermedad renal leve o moderada. Incluso la dieta con bajo contenido de carbohidratos, que es más rica en proteínas, "es aparentemente tan efectiva como las dietas mediterránea o reducidas en grasa para mejorar la función renal, lo que ocurriría con las tres dietas por la disminución de la presión y el aumento de la sensibilidad a la insulina que ocurre al adelgazar", explicó la doctora Iris Shai por e-mail.
Teleflex Incorporated (TFX), a leading global provider of medical devices for critical care and surgery, has announced that its subsidiary Hotspur Technologies, Inc., which Teleflex acquired in June 2012, completed CE marking requirements to market the company’s Arrow® GPSCath® Balloon Dilatation Catheters to the European Union. These novel products enable multiple vascular procedures to be performed with one dual-function catheter, potentially reducing procedure time and expense for both patients and medical professionals.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos